Genenta Science
SAEN
3 hedge funds and large institutions have $332K invested in Genenta Science in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
106% more capital inflows, than outflows
Capital inflows: $3.31K | Capital outflows: $1.61K
50% more funds holding
Funds holding: 2 → 3 (+1)
0.26% more ownership
Funds ownership: 0% → 0.26% (+0.26%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.61K |
SAEN Hedge Fund Activity: Q1 2022 in Review
3 of the 6,364 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (SAEN) for Q1 2022, worth a combined $332K — down 36% from $517K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SAEN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $3.31K. The largest seller was UBS Group, cutting an estimated $1.61K.
- 3 institutional investors held Genenta Science (SAEN) as of Q1 2022, up from 2 in Q4 2021.
- Funds reported $332K of Genenta Science stock for Q1 2022, down 36% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q1 2022 and 0 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q1 2022 was Bank of America, an estimated $3.31K added.
- The largest Genenta Science seller in Q1 2022 was UBS Group, an estimated $1.61K sold.
Based on aggregated 13F filings for Q1 2022.